Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedAug 13, 2014Vitamin B12 Methylcobalamin Injection USP 1000 mcg/mlMarketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug...Medical Supply Liquidators Llc · D-1520-1014Class IITerminatedAug 13, 2014Vitamin B12 Methylcobalamin with MIC Injection USP 1000 mcg/mlMarketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug...Medical Supply Liquidators Llc · D-1519-2014Class IITerminatedAug 13, 2014Alcohol-Free Hand SanitizerMicrobial Contamination of Non-Sterile ProductHLI dba Humphreyline Inc · D-1518-2014Class IITerminatedAug 13, 2014Tetrahydrozoline HCLCGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy.SST Corporation · D-1517-2014Class IIITerminatedAug 13, 2014CataflamFailed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.Novartis Pharmaceuticals Corp. · D-1516-2014Class IITerminatedAug 13, 2014Alprazolam TabletsPresence of Foreign Substance; tablets may contain stainless steel metal particulatesMckesson Packaging Services · D-1515-2014Class IITerminatedAug 13, 2014Risperdal CONSTANon-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sampleJanssen Pharmaceuticals, Inc. · D-1514-2014Class IIITerminatedAug 13, 2014buPROPion HCl Extended-Release TabletsFailed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.Wockhardt Usa Inc. · D-1513-2014Class ITerminatedAug 13, 2014SolirisPresence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.Alexion Pharmaceuticals, Inc. · D-1512-2014Class IITerminatedAug 13, 2014Cephalexin CapsulesCGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good...Caraco Pharmaceutical Laboratories, Ltd. · D-1511-2014Class IITerminatedAug 13, 2014Cephalexin CapsulesCGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good...Caraco Pharmaceutical Laboratories, Ltd. · D-1510-2014Class IITerminatedAug 6, 2014Alprazolam TabletsPresence of Foreign Substance; tablets may contain stainless steel metal particulatesSandoz Incorporated · D-1509-2014Class IITerminatedAug 6, 2014Benicar HCT TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.Daiichi Sankyo Pharma Development · D-1508-2014Class IITerminatedAug 6, 2014Benicar HCT TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.Daiichi Sankyo Pharma Development · D-1507-2014Class IITerminatedAug 6, 2014Benicar TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.Daiichi Sankyo Pharma Development · D-1506-2014Class IITerminatedAug 6, 2014Welchol TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1505-2014Class IITerminatedAug 6, 2014Tribenzor TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1504-2014Class IITerminatedAug 6, 2014Benicar HCT TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1503-2014Class IITerminatedAug 6, 2014Benicar TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1502-2014Class IITerminatedAug 6, 2014Azor TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1501-2014Class IITerminatedAug 6, 2014Losartan Potassium and Hydrochlorothiazide TabletsPresence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.Jubilant Cadista Pharmaceuticals Inc. · D-1500-2014Class IITerminatedAug 6, 2014triple therapyFailed Impurities/Degradation Specifications: This recall is due to out of specification for impurities test results obtained during stability testing for Lansoprazole.Teva Pharmaceuticals USA · D-1499-2014Class IITerminatedAug 6, 2014Fagron, Pentravan Plus Base 2.5 KgMicrobial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.Fagron, Inc · D-1498-2014Class IITerminatedAug 6, 2014Fagron, Pentravan Base 2.5 KgMicrobial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.Fagron, Inc · D-1497-2014Class IITerminatedAug 6, 2014Fagron, Phytobase CreamMicrobial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.Fagron, Inc · D-1496-2014Class IITerminatedAug 6, 2014Therametics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml containers in the Complexion...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1495-2014Class IITerminatedAug 6, 2014Dermamedics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml containers in the Dermamedics...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1494-2014Class IITerminatedAug 6, 2014Dermamedics Calm and Correct Cream 2 oz. containers in the Dermamedics Post Medical Procedure Kit with a SKU...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1493-2014Class IITerminatedAug 6, 2014Dermamedics Post Procedure Cream 1 oz. containers in the Dermamedics Post-Laser Treatment System with a SKU...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1492-2014Class IITerminatedAug 6, 2014Dermamedics Calm and Correct SerumMarketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1491-2014Class IITerminatedAug 6, 2014Dermamedics Complexion Repair Topical Rehydrating Emulsion which wasMarketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1490-2014Class IITerminatedAug 6, 2014Dermamedics Baby's Relief Calm and Repair Cream in 2 oz. containers with a SKU number of DM1016 and 0.25...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1489-2014Class IITerminatedAug 6, 2014Dermamedics Calm & Correct Cream in 2 oz. containers with SKU number DM1020Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1488-2014Class IITerminatedAug 6, 2014Dermamedics Post Procedure CreamMarketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1487-2014Class IIITerminatedAug 6, 2014OXYCODONE HYDROCHLORIDE C II Oral Solution USPFailed Stability Specifications: Out of specification result for preservative sodium benzoate.Boehringer Ingelheim Roxane Inc · D-1486-2014Class IIITerminatedAug 6, 2014Cardura XLFailed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.Pfizer Inc. · D-1485-2014Class IIITerminatedAug 6, 2014Aspirin DR Enteric Coated TabletsFailed Dissolution Specification; at the 12 month time interval.Mckesson Packaging Services · D-1483-2014Class IIOngoingJul 30, 2014Ceftriaxone 1 gm/50 mL D5WLack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to...Franck's Lab Inc dba Trinity Care Solutions · D-1482-2014Class IIOngoingJul 30, 2014Cefepime 2 gm/100 mL 0.9%NSLack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to...Franck's Lab Inc dba Trinity Care Solutions · D-1481-2014Class IIOngoingJul 30, 2014Ceftriaxone 2 gm/100 mL D5WLack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to...Franck's Lab Inc dba Trinity Care Solutions · D-1480-2014

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.